Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design

INTRODUCTION: Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organisation for HIV infected persons. However, once HIV infected patients have commenced ART in resource limited settings, the benefits of continued CTX prophylaxis are not known. The few studies that investigated the...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Contemp Clin Trials
Auteurs principaux: Anywaine, Zacchaeus, Abaasa, Andrew, Levin, Jonathan, Kasirye, Ronnie, Kamali, Anatoli, Grosskurth, Heiner, Munderi, Paula, Nunn, Andrew
Format: Artigo
Langue:Inglês
Publié: Elsevier 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542218/
https://ncbi.nlm.nih.gov/pubmed/26009024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2015.05.015
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires